#121 - Azra Raza, M.D.: Why we're losing the war on cancer
Azra Raza is a physician, scientist, author, and outspoken advocate for reconfiguring the current model of research in cancer. In this episode, Azra discusses the content of her book, The First Cell, which takes a critical look at the outdated models being used to study cancer resulting in a lack of progress in survival rates for cancer patients. Azra offers a solution which focuses on early detection and prevention, and she concludes with an optimistic outlook for the future of cancer research. We discuss:
- Azra's upbringing, interest in oncology, and the basis for writing her book [3:30];
- The lack of progress in cancer treatment over the decades [18:45];
- What is holding the oncology field back? [33:15];
- Do the purported advances in oncology reflect the billions of dollars spent on cancer research? [40:00];
- Economics of new cancer drugs—how small increases in survival come with staggering financial burdens [47:00];
- How good intentions can still lead to misaligned incentives and a broken system [1:03:00];
- Why 95% of new cancer drugs fail—a critical review of the cancer research model [1:11:15];
- Early detection and prevention—a potential solution to the cancer problem [1:22:30];
- Coping with the loss of her husband to cancer [1:46:00];
- Azra's optimistic view of the future [1:49:30]; and
- More.
Learn more: https://peterattiamd.com/ Show notes page for this episode: https://peterattiamd.com/azraraza Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on Facebook | Twitter | Instagram.
More description
Azra Raza is a physician, scientist, author, and outspoken advocate for reconfiguring the current model of research in cancer. In this episode, Azra discusses the content of her book, The First Cell, which takes a critical look at the outdated models being used to study cancer resulting in a lack of progress in survival rates for cancer patients. Azra offers a solution which focuses on early detection and prevention, and she concludes with an optimistic outlook for the future of cancer research. We discuss:
- Azra's upbringing, interest in oncology, and the basis for writing her book [3:30];
- The lack of progress in cancer treatment over the decades [18:45];
- What is holding the oncology field back? [33:15];
- Do the purported advances in oncology reflect the billions of dollars spent on cancer research? [40:00];
- Economics of new cancer drugs—how small increases in survival come with staggering financial burdens [47:00];
- How good intentions can still lead to misaligned incentives and a broken system [1:03:00];
- Why 95% of new cancer drugs fail—a critical review of the cancer research model [1:11:15];
- Early detection and prevention—a potential solution to the cancer problem [1:22:30];
- Coping with the loss of her husband to cancer [1:46:00];
- Azra's optimistic view of the future [1:49:30]; and
- More.
Learn more: https://peterattiamd.com/ Show notes page for this episode: https://peterattiamd.com/azraraza Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on Facebook | Twitter | Instagram.
2020-07-27
114 min
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.
No generated results are available for this episode yet.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.